Life sciences · Interventional Study
ClinicalTrials.gov · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05523375). This is a study registration, not published results. Lead sponsor: Pennington Biomedical Research Center. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 352 participants (ACTUAL). Conditions: Obesity, Diabetes Mellitus, Type 2, PreDiabetes. Interventions: BEHAVIORAL: Intensive Lifestyle Intervention. Primary outcome measures: Body weight (Percent Change) , Percent (%) Change from Baseline to Month 24. Brief summary: The primary aim is to test the effectiveness of an innovative 24-month pragmatic and scalable weight-loss centric approach using a collaborative care model that connects patients with a non-Primary Care Practitioner (PCP) health coach who delivers care remotely to patients through the patient portal of an electronic medical record (EMR).